RETEVMO 40 mg/1

RETEVMO 40 mg tablets are a prescription medication used to treat specific types of cancer. This oral medication is designed to target certain genetic mutations, offering a targeted approach to cancer therapy.

RETEVMO is primarily used in the treatment of advanced or metastatic cancers that harbor specific genetic alterations. It is often prescribed for cancers that have spread to other parts of the body or have not responded to other treatments. RETEVMO 40 mg tablets are designed to inhibit the activity of certain proteins that drive cancer growth, providing a targeted therapeutic option.

Common effects of RETEVMO may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Some users may also experience fatigue, dry skin, or changes in taste. These effects can vary from person to person and may not affect everyone who takes the medication.

RETEVMO should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

RETEVMO may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is important to discuss all current medications with your healthcare provider to ensure safe and effective use. Avoid consuming grapefruit or grapefruit juice, as it can affect the metabolism of RETEVMO.